BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 313034)

  • 1. Possible nonspecific immunopotentiation by 2,4-dinitrochlorobenzene sensitization in patients with Hodgkin's disease.
    Rubinstein A; Ghossein NA; Melamed J; Bosworth JL; Murphy RA
    Oncology; 1979; 36(1):23-6. PubMed ID: 313034
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Immune condition in patients with Hodgkin's disease.
    Zywicka-Lopaciuk H; Konopka L; Traczyk Z; Pawelski S; Sylwestrowicz T; Maślanka K; Arczyńska-Brojer E; Cieśluk S; Karpowicz M; Małkowska-Zwierz W
    Arch Immunol Ther Exp (Warsz); 1980; 28(1):153-60. PubMed ID: 6968189
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long term effects of radiation of T and B lymphocytes in peripheral blood of patients with Hodgkin's disease.
    Fuks Z; Strober S; Bobrove AM; Sasazuki T; McMichael A; Kaplan HS
    J Clin Invest; 1976 Oct; 58(4):803-14. PubMed ID: 135001
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of murine tumors upon delayed hypersensitivity to dinitrochlorobenzene. III. In vivo activity of the nonspecific suppressor cell.
    Jessup JM; Macek CM; Kahan BD; Pellis NR
    J Immunol; 1981 Nov; 127(5):2183-7. PubMed ID: 6457866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sensitization with DNCB in patients with leprosy].
    Stojaković M; Macanović K
    Med Arh; 1975; 29(2):121-2. PubMed ID: 1048992
    [No Abstract]   [Full Text] [Related]  

  • 6. Comparative studies of the proportions of T, B and zero lymphocytes and the degrees of blastic transformation of lymphocytes after stimulation by PHA and CON A in patients with Hodgkin's disease.
    Pluzańska A
    Haematol Blood Transfus; 1977; 20():203-7. PubMed ID: 305396
    [No Abstract]   [Full Text] [Related]  

  • 7. Comparison of multiple in vivo and in vitro parameters in untreated patients with Hodgkin's disease.
    Case DC; Hansen JA; Corrales E; Young CW; Dupont B; Pinsky CM; Good RA
    Cancer; 1976 Oct; 38(4):1807-15. PubMed ID: 1086708
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Splenic T and B lymphocytes and their mitogenic response in untreated Hodgkin's disease.
    Han T; Minowada J; Subramanian V; Barcos M; Kim U
    Cancer; 1980 Feb; 45(4):767-74. PubMed ID: 6965606
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Late hypersensitivity of the skin to DNCB in patients with Hodgkin's disease].
    Dziewulska-Bokiniec A; Lapińska M
    Nowotwory; 1980; 30(2):149-54. PubMed ID: 7413448
    [No Abstract]   [Full Text] [Related]  

  • 10. Peripheral blood T and B lymphocytes, in vitro stimulation with phytohemagglutinin, and sensitization with 2,4-dinitrochlorobenzene in Grave's disease.
    Maciel RM; Miki SS; Nicolau W; Mendes NF
    J Clin Endocrinol Metab; 1976 Mar; 42(3):583-7. PubMed ID: 767355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neoantigen response in patients successfully treated for lymphoma. A Southwest Oncology Group study.
    King GW; Grozea PC; Eyre HJ; LoBuglio AF
    Ann Intern Med; 1979 Jun; 90(6):892-5. PubMed ID: 375792
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunological studies in psoriasis. The quantitative evaluation of cell-mediated immunity in patients with psoriasis by experimental sensitization to 2,4-dinitrochlorobenzene.
    Obalek S; Haftek M; Sliński W
    Dermatologica; 1977; 155(1):13-25. PubMed ID: 303184
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Immunological aspects of Hodgkin's disease].
    Bianchini E
    Minerva Med; 1975 Feb; 66(8):365-70. PubMed ID: 1078722
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Disorders of cellular immunity in Hodgkin's disease].
    Burchardt K
    Pol Arch Med Wewn; 1981 Aug; 66(2):133-41. PubMed ID: 7033936
    [No Abstract]   [Full Text] [Related]  

  • 15. In vitro lymphocyte dysfunction in Hodgkin's disease.
    Graze PR; Perlin E; Royston I
    J Natl Cancer Inst; 1976 Feb; 56(2):239-43. PubMed ID: 130496
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigen-binding T and B lymphocytes in sensitization and unresponsiveness to dinitrochlorobenzene (DNCB) contact sensitivity.
    Polak L; Rydén A; Roelants GE
    Immunology; 1975 Mar; 28(3):479-84. PubMed ID: 1079198
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Quantitative study of T and B lymphocytes in Hodgkin's disease.
    Bensa JC; Micouin C; Schaerer R; Sotto JJ; Hollard D
    Biomedicine; 1977 Apr; 26(2):137-44. PubMed ID: 326312
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quantitative dinitrochlorobenzene (DNCB) responsivity and phytohemagglutinin (PHA) induced lymphocyte transformation in patients with lepromatous leprosy.
    Rea TH; Quismorio F; Harding B; Friou G; Levan N
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):250-5. PubMed ID: 945239
    [No Abstract]   [Full Text] [Related]  

  • 19. Lymphonodal response to sensitization with 2,4-dinitrochlorobenzene (DNCB) in laboratory rats.
    Lukács L; István M; Tóth P
    Neoplasma; 1986; 33(1):11-9. PubMed ID: 3960208
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of in vitro irradiation on mitogenic responsiveness of peripheral blood lymphocytes from untreated patients with Hodgkin's disease.
    Baral E; Blomgren H; Juhlin I
    Cancer; 1979 Oct; 44(4):1241-6. PubMed ID: 498012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.